Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85951-86000 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05431504
The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis
PHASE2
Not yet recruiting
53 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05437328
GD2/CD56 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05576818
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
PHASE3
Recruiting
66 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05429216
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
NA
Not yet recruiting
102 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT06645535
The Gut Microbiota and Metabolites in HFpEF
N/A
Enrolling by invitation
300 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05338619
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
PHASE2
Recruiting
77 participants
Started: Jun 30, 2022 · Completed: Mar 2, 2026
3 conditions
2 sponsors
13 locations
NCT05327296
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
PHASE3
Active, not recruiting
235 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2024
1 condition
1 sponsor
16 locations
NCT05176626
Long-term Effectiveness of the Antiobesity Medication Phentermine
PHASE4
Active, not recruiting
870 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
3 conditions
9 sponsors
4 locations
NCT05353907
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
N/A
Not yet recruiting
78 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
PHASE3
Recruiting
220 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
47 locations
NCT04990713
QoR40 Between Intercostal Block and Intercostal Block and Serratus Plane Catheter During VATS
NA
Recruiting
200 participants
Started: Jun 30, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT04648280
Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2028
1 condition
5 sponsors
10 locations
NCT05309993
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
NA
Recruiting
130 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
PHASE2
Not yet recruiting
200 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05604430
Pre-hospital Ventilation Clinical Study
N/A
Enrolling by invitation
500 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2030
6 conditions
1 sponsor
4 locations
NCT04605562
Umbrella Biomarker-Guided Therapy in NPC
PHASE2
Not yet recruiting
206 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05417984
RSA Restoris MultiCompartmental Knee
N/A
Not yet recruiting
33 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2029
1 condition
1 sponsor
0 locations
NCT05436496
CD19/70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05241561
Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients
PHASE2
Not yet recruiting
24 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT05531370
Implementation of Evidence-based Breathing Retraining for Patients with Asthma in Region Zealand
NA
Active, not recruiting
300 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05438368
GD2/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05163288
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C
PHASE3
Recruiting
53 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
14 locations
NCT05364827
CT Coronary Angiography Prior to CTO PCI
NA
Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05419843
Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia
PHASE2
Not yet recruiting
25 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2027
3 conditions
1 sponsor
0 locations
NCT05432882
CD19/22 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05436509
CD19/79b Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05223894
Treating Heart Failure With hiPSC-CMs
PHASE1/PHASE2
Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT05726526
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
NA
Recruiting
340 participants
Started: Jun 30, 2022 · Completed: Mar 30, 2026
2 conditions
1 sponsor
5 locations
NCT06026644
Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life
N/A
Active, not recruiting
170 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2026
1 condition
1 sponsor
13 locations
NCT05206838
Achilles Tendon for the Treatment of Gluteus Medius Insufficiency
NA
Recruiting
44 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2028
4 conditions
4 sponsors
1 location
NCT06019507
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
PHASE2
Active, not recruiting
12 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT05141682
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
PHASE1/PHASE2
Recruiting
27 participants
Started: Jun 29, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
2 locations
NCT05134935
Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years.
NA
Active, not recruiting
90 participants
Started: Jun 29, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
PHASE3
Recruiting
168 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2022
2 conditions
2 sponsors
9 locations
NCT05566275
Remote Cognitive Assessment for Surgical Patients
N/A
Recruiting
30 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2023
2 conditions
2 sponsors
1 location
NCT04814446
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
PHASE3
Recruiting
146 participants
Started: Jun 29, 2022 · Completed: Jun 29, 2026
1 condition
1 sponsor
1 location
NCT05257408
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
PHASE3
Active, not recruiting
381 participants
Started: Jun 29, 2022 · Completed: Mar 31, 2026
3 conditions
2 sponsors
117 locations
NCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
PHASE1
Recruiting
10 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05102747
Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
NA
Active, not recruiting
504 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2027
2 conditions
2 sponsors
16 locations
NCT05479578
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
PHASE1
Active, not recruiting
7 participants
Started: Jun 29, 2022 · Completed: May 1, 2025
3 conditions
2 sponsors
1 location
NCT05173961
A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy
NA
Active, not recruiting
20 participants
Started: Jun 29, 2022 · Completed: Nov 30, 2025
2 conditions
2 sponsors
1 location
NCT06156891
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
PHASE2
Recruiting
60 participants
Started: Jun 29, 2022 · Completed: Jul 30, 2025
1 condition
1 sponsor
1 location
NCT05539560
The Effect of Olfactory Training in Patients With COVID-19 Induced Olfactory Dysfunction
NA
Recruiting
65 participants
Started: Jun 29, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05164016
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
N/A
Active, not recruiting
21 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
8 conditions
1 sponsor
3 locations
NCT05421780
Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome
NA
Active, not recruiting
16 participants
Started: Jun 29, 2022 · Completed: Jul 31, 2024
3 conditions
2 sponsors
1 location
NCT05415020
Determining the Utility of a Behavioral Intervention in Chronic Migraine
NA
Recruiting
60 participants
Started: Jun 29, 2022 · Completed: Aug 14, 2026
6 conditions
2 sponsors
1 location
NCT05334719
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
N/A
Active, not recruiting
500 participants
Started: Jun 29, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT04939272
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
8 participants
Started: Jun 29, 2022 · Completed: Feb 24, 2026
2 conditions
2 sponsors
1 location
NCT05293470
A Post Marketing Surveillance on Piqray in Korea
N/A
Recruiting
900 participants
Started: Jun 29, 2022 · Completed: May 12, 2027
1 condition
1 sponsor
17 locations
NCT05356702
The Brain Health Study: A Pragmatic, Patient-Centered Trial
NA
Active, not recruiting
3,417 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2025
2 conditions
2 sponsors
5 locations
Previous
1
More pages
1717
1718
1719
1720
1721
1722
1723
More pages
2369
Next